EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Lunaphore, a Switzerland-based cancer research and diagnostics equipment spinout of EPFL, added CHF2m ($2m) to close a series C round already backed by medical products group PHC Holdings at $25.6m on Tuesday. The extension was supplied by Swiss Entrepreneurs Fund, a joint investment vehicle formed by startup support organisation Swiss Entrepreneurs Foundation, insurance provider Swiss…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.